Intravenous administration of equine-derived whole IgG antivenom does not induce early adverse reactions in non-envenomed horses and cows

Biologicals

Volumn 38, Issue 6, 2010, Pages 664-669

  Estrada, Ricardo ^a   Herrera, María ^a   Segura, Álvaro ^a   Araya, Javier ^a   Boschini, Carlos ^a   Gutiérrez, José María ^a   Leon G ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Antivenom; Caprylic acid; Cow; Early adverse reactions; Horse; Snakebite

Indexed keywords

ALBUMIN; EQUINE DERIVED WHOLE IMMUNOGLOBULIN G SNAKE ANTIVENOM; FIBRINOGEN; IMMUNOGLOBULIN G ANTIBODY; OCTANOIC ACID; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; COW; DRUG ERUPTION; DRUG FORMULATION; DRUG TOLERABILITY; ERYTHROCYTE AGGREGATION; HORSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN CONTENT; SERUM SICKNESS; SKIN ALLERGY; SKIN TEST;

ANIMALS; ANTIVENINS; CATTLE; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HORSES; IMMUNOGLOBULIN G; INFUSIONS, INTRAVENOUS; SNAKE BITES;

ANIMALIA; EQUIDAE;

EID: 78650244503     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2010.08.002     Document Type: Article

References (35)

1. Lalloo D.G., Theakston R.D. Snake antivenoms. J Toxicol Clin Toxicol 2003, 41:277-290.
2. Gutiérrez J.M., León G. Snake antivenoms: technological, clinical and public health issues. Animal toxins: state of the art 2009, 393-421. Sermograf, Belo Horizonte. UFMG (Ed.).
3. Theakston R.D., Warrell D.A., Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 2003, 41:541-557.
4. Williams D.J., Jensen S.D., Nimorakiotakis B., Müller R., Winkel K.D. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea. Toxicon 2007, 49:780-792.
5. Kobrynski L.J. Anaphylaxis. Clin Ped Emerg Med 2007, 8:110-116.
6. Sutherland S.K. Serum reactions. An analysis of commercial antivenoms and the possible role of anticomplementary activity in de-novo reactions to antivenoms and antitoxins. Med J Aust 1977, 1:613-615.
7. Herrera M., León G., Segura A., Meneses F., Lomonte B., Chippaux J.P., et al. Factors associated with adverse reactions induced by whole IgG preparations: comparison between horse, sheep and camel IgGs. Toxicon 2005, 46:775-781.
8. Sevcik C., Díaz P., D'Suze G. On the presence of antibodies against bovine, equine and poultry immunoglobulins in human IgG preparations, and its implications on antivenom production. Toxicon 2008, 51:10-16.
9. Malasit P., Warrell D.A., Chanthavanich P., Viravan C., Mongkolsapaya J., Singhthong B., et al. Prediction, prevention and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites. Br Med J 1986, 292:17-20.
10. Otero R., Cardoso J.L.C., Dias W., Higashi H.G., Nuñez V., Díaz A., et al. A randomized blinded comparative trial of one pepsin-digested and two whole IgG antivenoms in Bothrops snake bites in Urabá, Colombia. Am J Trop Med Hyg 1998, 58:183-189.
11. Otero R., León G., Gutiérrez J.M., Rojas G., Toro M.F., Barona J., et al. Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans R Soc Trop Med Hyg 2006, 100:1173-1182.
12. ®, un antiveneno polivalente producido en México. Iatreia 2007, 20:244-262.
13. León G., Lomonte B., Gutiérrez J.M. Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. Toxicon 2005, 45:123-128.
14. Rojas G., Jiménez J.M., Gutiérrez J.M. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon 1994, 32:351-363.
15. Otero R., Gutiérrez J.M., Rojas G., Nuñez V., Díaz A., Miranda E., et al. A randomized blind clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops snake bites in Colombia. Correlation between safety and biochemical characteristics of antivenoms. Toxicon 1999, 37:895-908.
16. Angulo Y., Estrada R., Gutiérrez J.M. Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (crotalinae) antivenom. Toxicon 1997, 35:81-90.
17. Schosinsky K., Vargas M., Vinocour G., González O.M., Brilla E., Gutiérrez A. Manual de Técnicas de Laboratorio. Química Clínica 1983, Universidad de Costa Rica, San José.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. García M., Monge M., León G., Lizano S., Segura E., Solano G., et al. Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation. Biologicals 2002, 30:143-151.
20. LoVecchio F., Klemens J., Roundy E.B., Klemens A. Serums sickness following administration of Antivenin (Crotalidae) Polyvalent in 181 cases of presumed rattlesnake envenomation. Wilderness Environ Med 2003, 14:220-221.
21. Council of International Organizations of Medical Sciences (CIOMS) The international guiding principles for biomedical research involving animals 1986, Z.Bankowski & N. Howard-Jones, Geneva.
22. León G., Rodríguez M., Rucavado A., Fernandez I., Lomonte B., Gutiérrez J.M. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations. Biologicals 2007, 35:5-11.
23. 2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. Toxicon 2001, 39:793-801.
24. Moran N.F., Newman W.J., Theakston R.D.G., Warrell D.A., Wilkinson D. High incidence of early anaphylactoid reaction to SAIMR polyvalent snake antivenom. Trans R Soc Trop Med Hyg 1998, 92:69-70.
25. Hui F.W., Marcopito L.F., Cardoso J.L.C., França F.O.S., Malaque C.M.S., Ferrari R.A., et al. Sequential randomized and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for Bothrops snake bites. Br Med J 1999, 318:1451-1453.
26. Premawardhena A.P., de Silva C.E., Fonseka M.M.D., Gunatilake S.B., da Silva H.J. Low dose subcutaneous adrenalin to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. Br Med J 1999, 318:1041-1043.
27. Ariaratnam C.A., Sjostrom L., Raziek Z., Kularatne A.M., Arachichi R.W.K., Sheriff M.H.R., et al. An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans R Soc Trop Med Hyg 2001, 95:74-80.
28. Gawarammana I.B., Kularatne S.A.M., Dissanayake W.P., Kumarasiri R.P.V., Senanayake N., Ariyasena H. Parallel infusion of hydrocortisone ± chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. A randomized, double-blind, placebo-controlled study. Med J Aust 2004, 180:20-23.
29. Rojnuckarin P. Antivenom skin test: theory versus practice. Acta Trop 2009, 109:86.
30. Warrell D.A. WHO/SEARO guidelines for the clinical management of snake bites in the southeast Asian region. Southeast Asian J Trop Med Public Health 1999, 30:1-85.
31. Cupo P., Azevedo-Marques M.M., Sarti W., Hering S.E. Proposal of abolition of the skin sensitivity test before equine rabies immune globulin application. Rev Inst Med Trop São Paulo 2001, 43:51-53.
32. León G., Segura A., Herrera M., Otero R., França F.O.S., Barbaro K.C., et al. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration. Trans R Soc Trop Med Hyg 2008, 102:1115-1119.
33. Hughes N.C., Gardner B. Red cell agglutination: the first description by Creite (1869), and further observations made by Landois (1875) and Landsteiner (1901). Br J Haematol 2002, 119:889-893.
34. Grant C.K. Complement " specificity" and interchangeability: measurement of hemolytic complement levels and use of the complement-fixation test with sera from common domesticated animals. Am J Vet Res 1977, 38:1611-1617.
35. Gutiérrez J.M. Snakebite envenomation in Central America. Handbook of venoms and toxins of reptiles 2009, 491-507. CRC Press, Boca Raton. S.P. MacKessy (Ed.).